HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - NYSE:HIMS - US4330001060 - Common Stock
55.5 USD
+3.74 (+7.23%)
55 USD
-0.5 (-0.9%)
Overall HIMS gets a fundamental rating of 6 out of 10. We evaluated HIMS against 101 industry peers in the Health Care Providers & Services industry. HIMS has an average financial health and profitability rating. HIMS shows excellent growth, but is valued quite expensive already. These ratings could make HIMS a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
In the past year HIMS was profitable.
HIMS had a positive operating cash flow in the past year.
In the past 5 years HIMS reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
With an excellent Return On Assets value of 10.31%, HIMS belongs to the best of the industry, outperforming 95.05% of the companies in the same industry.
The Return On Equity of HIMS (34.41%) is better than 96.04% of its industry peers.
HIMS has a Return On Invested Capital of 6.74%. This is in the better half of the industry: HIMS outperforms 68.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 34.41% | ||
| ROIC | 6.74% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 9.62%, HIMS belongs to the top of the industry, outperforming 93.07% of the companies in the same industry.
HIMS's Operating Margin of 6.80% is fine compared to the rest of the industry. HIMS outperforms 67.33% of its industry peers.
The Gross Margin of HIMS (76.20%) is better than 89.11% of its industry peers.
HIMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.8% | ||
| PM (TTM) | 9.62% | ||
| GM | 76.2% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
HIMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, HIMS has more shares outstanding
Compared to 5 years ago, HIMS has more shares outstanding
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
HIMS has an Altman-Z score of 7.62. This indicates that HIMS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of HIMS (7.62) is better than 92.08% of its industry peers.
HIMS has a debt to FCF ratio of 8.11. This is a slightly negative value and a sign of low solvency as HIMS would need 8.11 years to pay back of all of its debts.
With a Debt to FCF ratio value of 8.11, HIMS perfoms like the industry average, outperforming 57.43% of the companies in the same industry.
A Debt/Equity ratio of 1.72 is on the high side and indicates that HIMS has dependencies on debt financing.
HIMS's Debt to Equity ratio of 1.72 is on the low side compared to the rest of the industry. HIMS is outperformed by 70.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 8.11 | ||
| Altman-Z | 7.62 |
ROIC/WACC0.77
WACC8.7%
2.3 Liquidity
A Current Ratio of 4.98 indicates that HIMS has no problem at all paying its short term obligations.
HIMS has a Current ratio of 4.98. This is amongst the best in the industry. HIMS outperforms 93.07% of its industry peers.
HIMS has a Quick Ratio of 4.46. This indicates that HIMS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.46, HIMS belongs to the top of the industry, outperforming 92.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.98 | ||
| Quick Ratio | 4.46 |
3. Growth
3.1 Past
HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 900.00%, which is quite impressive.
HIMS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 60.35% yearly.
HIMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 88.69%.
HIMS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 75.77% yearly.
EPS 1Y (TTM)900%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%183.33%
Revenue 1Y (TTM)88.69%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%72.61%
3.2 Future
The Earnings Per Share is expected to grow by 41.75% on average over the next years. This is a very strong growth
Based on estimates for the next years, HIMS will show a very strong growth in Revenue. The Revenue will grow by 20.95% on average per year.
EPS Next Y11.07%
EPS Next 2Y23.28%
EPS Next 3Y24.28%
EPS Next 5Y41.75%
Revenue Next Year59.8%
Revenue Next 2Y38.24%
Revenue Next 3Y31.33%
Revenue Next 5Y20.95%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 69.38 indicates a quite expensive valuation of HIMS.
Compared to the rest of the industry, the Price/Earnings ratio of HIMS is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.30, HIMS is valued quite expensively.
Based on the Price/Forward Earnings ratio of 67.63, the valuation of HIMS can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as HIMS.
HIMS is valuated expensively when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 69.38 | ||
| Fwd PE | 67.63 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as HIMS.
HIMS's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 104.97 | ||
| EV/EBITDA | 74.37 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HIMS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as HIMS's earnings are expected to grow with 24.28% in the coming years.
PEG (NY)6.27
PEG (5Y)1.15
EPS Next 2Y23.28%
EPS Next 3Y24.28%
5. Dividend
5.1 Amount
HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
55.5
+3.74 (+7.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners81.86%
Inst Owner Change9.04%
Ins Owners10.73%
Ins Owner Change-0.54%
Market Cap12.54B
Analysts70
Price Target51.38 (-7.42%)
Short Float %36.25%
Short Ratio1.91
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)36.23%
Min EPS beat(2)10.29%
Max EPS beat(2)62.17%
EPS beat(4)4
Avg EPS beat(4)185.99%
Min EPS beat(4)4.62%
Max EPS beat(4)666.87%
EPS beat(8)7
Avg EPS beat(8)152.2%
EPS beat(12)11
Avg EPS beat(12)111.23%
EPS beat(16)12
Avg EPS beat(16)74.99%
Revenue beat(2)1
Avg Revenue beat(2)1.79%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)6.75%
Revenue beat(4)3
Avg Revenue beat(4)1.72%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.23%
Revenue beat(12)9
Avg Revenue beat(12)2.03%
Revenue beat(16)13
Avg Revenue beat(16)3.23%
PT rev (1m)0%
PT rev (3m)7.12%
EPS NQ rev (1m)-11.37%
EPS NQ rev (3m)-32.59%
EPS NY rev (1m)-11.98%
EPS NY rev (3m)-5.16%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)-1.31%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 69.38 | ||
| Fwd PE | 67.63 | ||
| P/S | 6.23 | ||
| P/FCF | 104.97 | ||
| P/OCF | 47.95 | ||
| P/B | 22.29 | ||
| P/tB | 31.03 | ||
| EV/EBITDA | 74.37 |
EPS(TTM)0.8
EY1.44%
EPS(NY)0.82
Fwd EY1.48%
FCF(TTM)0.53
FCFY0.95%
OCF(TTM)1.16
OCFY2.09%
SpS8.91
BVpS2.49
TBVpS1.79
PEG (NY)6.27
PEG (5Y)1.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 34.41% | ||
| ROCE | 8.53% | ||
| ROIC | 6.74% | ||
| ROICexc | 23.47% | ||
| ROICexgc | 35.76% | ||
| OM | 6.8% | ||
| PM (TTM) | 9.62% | ||
| GM | 76.2% | ||
| FCFM | 5.94% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score6
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 8.11 | ||
| Debt/EBITDA | 5.84 | ||
| Cap/Depr | 486.96% | ||
| Cap/Sales | 7.06% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 157.56% | ||
| Profit Quality | 61.73% | ||
| Current Ratio | 4.98 | ||
| Quick Ratio | 4.46 | ||
| Altman-Z | 7.62 |
F-Score6
WACC8.7%
ROIC/WACC0.77
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)900%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%183.33%
EPS Next Y11.07%
EPS Next 2Y23.28%
EPS Next 3Y24.28%
EPS Next 5Y41.75%
Revenue 1Y (TTM)88.69%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%72.61%
Revenue Next Year59.8%
Revenue Next 2Y38.24%
Revenue Next 3Y31.33%
Revenue Next 5Y20.95%
EBIT growth 1Y821.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year364.13%
EBIT Next 3Y97.59%
EBIT Next 5Y58.64%
FCF growth 1Y927.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y922.97%
OCF growth 3YN/A
OCF growth 5YN/A